Anika Therapeutics Inc.

NASDAQ: ANIK · Real-Time Price · USD
8.90
0.26 (3.01%)
At close: Aug 15, 2025, 12:20 PM

Anika Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
55.63M 72.87M 86.33M 94.39M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a -17.77M
Other Long-Term Assets
13.62M 18.67M 17.22M 20.29M
Receivables
23.59M 35.96M 34.63M 29.84M
Inventory
23.81M 46.39M 39.77M 36.01M
Other Current Assets
10.62M 8.1M 8.83M 8.29M
Total Current Assets
113.65M 163.31M 169.55M 168.53M
Property-Plant & Equipment
64.68M 74.97M 78.97M 68.56M
Goodwill & Intangibles
9.62M 12.2M 81.94M 90.16M
Total Long-Term Assets
89.09M 107.32M 179.58M 179.01M
Total Assets
202.74M 270.63M 349.13M 347.54M
Account Payables
5.62M 9.86M 9.07M 7.63M
Deferred Revenue
n/a n/a n/a 16.13M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
7.67M 3.14M 5.46M 4.32M
Total Current Liabilities
23.31M 31.06M 27.91M 29.8M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
1.43M 404K 398K 1.26M
Total Long-Term Liabilities
25.45M 27.31M 35.65M 30.66M
Total Liabilities
48.75M 58.37M 63.56M 60.45M
Total Debt
25.93M 29.04M 30.89M 19.24M
Common Stock
144K 147K 146K 144K
Retained Earnings
71.67M 128.05M 210.72M 225.58M
Comprehensive Income
-6.78M -5.94M -6.44M -5.72M
Shareholders Equity
153.99M 212.26M 285.56M 287.08M
Total Investments
n/a 4.63M n/a -17.77M